Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,022.17 -13.52 (-0.27%) Dow
37,941.10 +125.18 (+0.33%) Nasdaq
15,601.70 -56.12 (-0.36%) Bitcoin USD
57,020.81 -3,313.57 (-5.49%) CMC Crypto 200
1,185.58 -153.48 (-11.45%)
Johnson & Johnson (JNJ)
| Previous close | 144.59 |
| Open | 148.74 |
| Bid | 150.83 x 900 |
| Ask | 150.85 x 900 |
| Day's range | 147.62 - 151.40 |
| 52-week range | 143.13 - 175.97 |
| Volume | |
| Avg. volume | 7,644,877 |
| Market cap | 363.925B |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | 20.33 |
| EPS (TTM) | 7.43 |
| Earnings date | 17 Jul 2024 |
| Forward dividend & yield | 4.96 (3.43%) |
| Ex-dividend date | 20 May 2024 |
| 1y target est | 172.98 |
CNN BusinessJohnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuits
Johnson & Johnson is moving forward with a proposed settlement of tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer.
- Reuters
UPDATE 1-J&J advances $6.48 billion settlement of talc cancer lawsuits
Johnson & Johnson said on Wednesday it is moving forward with a $6.48 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ovarian cancer. The deal would allow it to resolve the lawsuits through a third bankruptcy filing of a subsidiary company. It will begin a three month voting period in hopes of reaching consensus on a settlement of all current and future ovarian cancer claims.
Associated Press FinanceJ&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer. The lawsuits filed against J&J had alleged its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs. The claims contributed to drop in J&J’s sales of baby powder, prompting the company to stop selling its talc-based products in 2020.
